Medindia

X

MDS to Release First-Quarter 2010 Financial Results

Friday, March 5, 2010 General News J E 4
Advertisement
Annual and Special Meeting of Shareholders to be Held March 11 in Ottawa

TORONTO, March 4 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that the Company will report its first-quarter 2010 financial results on Tuesday, March 16, 2010.

The Company will also host a conference call for analysts with Steve West, Chief Executive Officer, and Peter Dans, Senior Vice-President and Chief Financial Officer, to discuss the results. The call will be Webcast live at 9:30 a.m. EST.

Interested parties may access the live Webcast of the conference call from the MDS Website at www.mdsinc.com. Following the call, an audio archive will be available on the Website in the "For Investors" section under "Webcasts & Presentations" at http://www.mdsinc.com/investors/webcasts_presentations.asp.

MDS Annual and Special Meeting of Shareholders

On Thursday, March 11, 2010, MDS will hold its Annual and Special Meeting of Shareholders at 11 a.m. EST at the Brookstreet Hotel in Ottawa. The Meeting will be Webcast live at www.mdsinc.com, and will also be archived form at http://www.mdsinc.com/investors/webcasts_presentations.asp.

About MDS

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that customers need for the development of drugs and the diagnosis and treatment of disease. MDS Inc. is a leading global provider of innovative technologies for use in medical imaging and radiotherapeutics, sterilization, and pharmaceutical contract research. MDS has more than 2,400 highly skilled people in nine countries. Find out more at www.mdsinc.com.

SOURCE MDS Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Record Contracts Signed in Jan + Feb for Zanett; O...
S
STELARA(TM) and REMICADE(R) Data in Treatment of P...